dc.creator | Herrera M.I. | |
dc.creator | Kölliker-Frers R.A. | |
dc.creator | Otero-Losada M. | |
dc.creator | Perez Lloret S. | |
dc.creator | Filippo M. | |
dc.creator | Tau J. | |
dc.creator | Capani F. | |
dc.creator | Villa A.M. | |
dc.date.accessioned | 2020-09-02T22:20:27Z | |
dc.date.accessioned | 2022-11-08T20:19:20Z | |
dc.date.available | 2020-09-02T22:20:27Z | |
dc.date.available | 2022-11-08T20:19:20Z | |
dc.date.created | 2020-09-02T22:20:27Z | |
dc.date.issued | 2019 | |
dc.identifier | 10, , - | |
dc.identifier | 16642295 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4874 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143118 | |
dc.language | en | |
dc.publisher | Frontiers Media S.A. | |
dc.subject | biomarker potential | |
dc.subject | cytokines | |
dc.subject | disability progression | |
dc.subject | expanded disability status scale | |
dc.subject | neurofilament heavy chain phosphoform | |
dc.subject | relapsing-remitting multiple sclerosis | |
dc.subject | cytokine | |
dc.subject | intercellular adhesion molecule 1 | |
dc.subject | interleukin 17 | |
dc.subject | interleukin 1beta | |
dc.subject | interleukin 6 | |
dc.subject | interleukin 8 | |
dc.subject | monocyte chemotactic protein 1 | |
dc.subject | neurofilament H protein | |
dc.subject | neurofilament protein | |
dc.subject | transforming growth factor beta1 | |
dc.subject | tumor necrosis factor | |
dc.subject | unclassified drug | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | axonal injury | |
dc.subject | case study | |
dc.subject | clinical article | |
dc.subject | clinical evaluation | |
dc.subject | controlled study | |
dc.subject | correlational study | |
dc.subject | cross-sectional study | |
dc.subject | deterioration | |
dc.subject | disease exacerbation | |
dc.subject | disease marker | |
dc.subject | enzyme linked immunosorbent assay | |
dc.subject | Expanded Disability Status Scale | |
dc.subject | feasibility study | |
dc.subject | female | |
dc.subject | human | |
dc.subject | immunomodulation | |
dc.subject | male | |
dc.subject | metabolic disorder | |
dc.subject | multiple sclerosis | |
dc.subject | observational study | |
dc.subject | pilot study | |
dc.subject | protein blood level | |
dc.subject | protein phosphorylation | |
dc.subject | scoring system | |
dc.title | A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis | |
dc.type | Article | |